Managing Ipilimumab-Induced Hypophysitis: Challenges and Current Therapeutic Strategies by Tsoli M, Kaltsas G, Angelousi A, Alexandraki K, Randeva H, Kassi E

Subjects: Get full text

Hypoparathyroidism: an uncommon adverse effect of treatment with durvalumab by Alexander Kreze, Matěj Homer, Tereza Barešová, Kristina Klemperová

Subjects: Get full text

Incidence and severity of immune-related hepatitis after dual checkpoint therapy is linked to younger age independent of herpes virus immunity by Zhen Zhang, David Rafei-Shamsabadi, Saskia Lehr, Nico Buettner, Rebecca Diehl, Daniela Huzly, David J Pinato, Robert Thimme, Frank Meiss, Bertram Bengsch

Subjects: Get full text

Nivolumab-induced lichen planus responsive to dupilumab treatment in a patient with stage III C melanoma by Sarah Kamsiah Zemlok, BA, Sulaikha Buuh, BA, Regina Brown, MD, MPH, Michael Murphy, MD, Upendra P. Hegde, MD, Janelle R. Mallett, MD, MBA

Subjects: Get full text

Immune Checkpoint Inhibitors Related to Cardiotoxicity by Ru Chen, Min Zhou, Feng Zhu

Subjects: Get full text

Editorial: Gastrointestinal cancer immune response and immune related adverse effects by Ti Wen, Yanhong Deng, Yanhong Deng, Bo Qin

Subjects: Get full text

Association Between Clinical Factors and Result of Immune Checkpoint Inhibitor Related Myasthenia Gravis: A Single Center Experience and Systematic Review by Jiayu Shi, Ying Tan, Yangyu Huang, Ke Li, Jingwen Yan, Yuzhou Guan, Li Zhang

Subjects: Get full text

Immune checkpoint inhibitor-associated diabetic ketoacidosis and insulin-dependent diabetes: a case report by Yungee Jung, Anthony Lau, Joseph Bednarczyk

Subjects: Get full text

Clinical Outcomes of Patients With Metastatic NSCLC After Discontinuation of Immunotherapy Because of Immune-Related Adverse Effects by Lysanne A. Lievense, MD, PhD, Peter Heukels, MD, PhD, Nico C. van Walree, MD, Cor H. van der Leest, MD, PhD

Subjects: Get full text

Nivolumab‐induced celiac‐like enteropathy in patient with metastatic renal cell carcinoma: Case report and review of the literature by Lucie Duval, Sarah Habes, Thierry Chatellier, Pascale Guerzider, Céline Bossard, Claude Masliah, Isabelle Archambeaud, Yann Touchefeu, Tamara Matysiak‐Budnik

Subjects: Get full text

PD-L1 Targeting Immune-Microbubble Complex Enhances Therapeutic Index in Murine Colon Cancer Models by Daehyun Kim, Seung Soo Lee, Hyungwon Moon, So Yeon Park, Hak Jong Lee

Subjects: Get full text

Association of Immune-Related Adverse Effects and Survival in Solid Tumor Patients Treated with PD1 Inhibitors by Akhil Kapoor, Vanita Noronha, Vijay M. Patil, Amit Joshi, Nandini Menon, Amit Kumar, Abhishek Mahajan, Amit Janu, Rajiv Kumar, Kumar Prabhash

Subjects: Get full text

Effects of immune checkpoint inhibitor associated endocrinopathies on cancer survival by Lisa Yang, Sruthi Murthy, Alessio Cortellini, Alessio Cortellini, Emma A. Lim, Michael Gonzalez, David J. Pinato, David J. Pinato, Mariana Abdel-Malek, Sarah Mahmoud, Niamh M. Martin, Niamh M. Martin

Subjects: Get full text

Optic Neuritis Possibly Induced by Anti-PD-L1 Antibody Treatment in a Patient with Non-Small Cell Lung Carcinoma by Sotaro Mori, Takuji Kurimoto, Kaori Ueda, Hiroko Enomoto, Mari Sakamoto, Yukako Keshi, Yuko Yamada, Makoto Nakamura

Subjects: Get full text

Extending traditional antibody therapies: Novel discoveries in immunotherapy and clinical applications by Charles Shin, Sung Soo Kim, Yong Hwa Jo

Subjects: Get full text

Univariable and multivariable Mendelian randomization study identified the key role of gut microbiota in immunotherapeutic toxicity by Baike Liu, Zheran Liu, Tianxiang Jiang, Xiangshuai Gu, Xiaonan Yin, Zhaolun Cai, Xiaoqiao Zou, Lei Dai, Bo Zhang

Subjects: Get full text

Risk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated With Radiotherapy by Feliciano Barrón, Roberto Sánchez, Marisol Arroyo-Hernández, Carolina Blanco, Zyanya L. Zatarain-Barrón, Rodrigo Catalán, Maritza Ramos-Ramírez, Andrés F. Cardona, Andrés F. Cardona, Andrés F. Cardona, Diana Flores-Estrada, Oscar Arrieta

Subjects: Get full text

Editorial: Management of Immune-Related Adverse Events for Patients Undergoing Treatment With Checkpoint Inhibitors by Bernardo Leon Rapoport, Bernardo Leon Rapoport

Subjects: “…immune related adverse effects…”
Get full text

Evaluation and management of acute high-grade immunotherapy-related neurotoxicity by Marcelo Sandoval, MD, Adriana H. Wechsler, MD, Zahra Alhajji, MD, Jayne Viets-Upchurch, MD, Patricia Brock, MD, Demis N. Lipe, MD, Aisha Al-breiki, MD, Sai-Ching J. Yeung, MD

Subjects: Get full text

Intestinal Microbiome Associated With Immune-Related Adverse Events for Patients Treated With Anti-PD-1 Inhibitors, a Real-World Study by Wenhui Liu, Wenhui Liu, Fang Ma, Bao Sun, Bao Sun, Yiping Liu, Yiping Liu, Haoneng Tang, Jianquan Luo, Jianquan Luo, Huiqing Chen, Huiqing Chen, Zhiying Luo, Zhiying Luo

Subjects: Get full text